Is UFP Technologies Inc (UFPT) overvalued? · P/E 26, rev $154.6M
UFP Technologies Inc (UFPT) is a medical devices company listed on NASDAQ.
This page asks whether UFP Technologies Inc (UFPT) looks expensive on cached numbers — not a short thesis.
Latest reported UFPT revenue for 2025-09-30 was $154.6M. Net income was $16.4M. Revenue was up 6.5% from 2024-09-30 to 2025-09-30. UFPT currently screens at market cap $1.76B and trailing P/E 26.0.
UFPT currently screens at market cap $1.76B and trailing P/E 26.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next UFPT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the UFPT stock page for the full model, not this heading.
Not investment advice.